Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature

Posterior reversible encephalopathy syndrome (PRES) is a clinical entity characterized by acute neurological symptoms such as severe headache, seizures, and visual disturbance, and by typical reversible lesion on brain magnetic resonance (MR) images. Since PRES is thought to be caused by vascular en...

Descripción completa

Detalles Bibliográficos
Autores principales: Deguchi, Shoichi, Mitsuya, Koichi, Nakasu, Yoko, Hayashi, Nakamasa, Katagiri, Hirohisa, Murata, Hideki, Wasa, Junji, Takahashi, Mitsuru, Endo, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869870/
https://www.ncbi.nlm.nih.gov/pubmed/29067537
http://dx.doi.org/10.1007/s10637-017-0521-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869870/
https://www.ncbi.nlm.nih.gov/pubmed/29067537
http://dx.doi.org/10.1007/s10637-017-0521-5

Ejemplares similares